4402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry

OBJECTIVES/GOALS: Little is known about the effect of hemodilution with crystalloid on blood coagulation in obstetric patients. The purpose of our study was to examine the impact of hemodilution on components of blood coagulation using rotational thromboelastometry (ROTEM®) in term parturients METHO...

Full description

Bibliographic Details
Main Authors: Chloe Getrajdman, Matthew Sison, Hung-Mo Lin, Daniel Katz
Format: Article
Language:English
Published: Cambridge University Press 2020-06-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866120004343/type/journal_article
_version_ 1811155100380430336
author Chloe Getrajdman
Matthew Sison
Hung-Mo Lin
Daniel Katz
author_facet Chloe Getrajdman
Matthew Sison
Hung-Mo Lin
Daniel Katz
author_sort Chloe Getrajdman
collection DOAJ
description OBJECTIVES/GOALS: Little is known about the effect of hemodilution with crystalloid on blood coagulation in obstetric patients. The purpose of our study was to examine the impact of hemodilution on components of blood coagulation using rotational thromboelastometry (ROTEM®) in term parturients METHODS/STUDY POPULATION: This is a prospective, observational pilot study including 35 healthy, pregnant patients at term (≥37 weeks) without history of bleeding or clotting disorder or on medication affecting coagulation. Venous blood samples were collected from all patients and divided into specimen tubes to generate varying degrees of hemodilution with Plasma-Lyte (0%, 20%, 25%, 30%, 35%, 40%, 45%, 55%, 60%, 65%, 70%, 75%, 80%). Rotational thromboelastometry was then performed on samples to assess for coagulation changes. RESULTS/ANTICIPATED RESULTS: EXTEM (extrinsically activated assay) clotting time (CT) became prolonged at 65% hemodilution and above, and the median CT was in the coagulopathic range (>80 seconds) at a dilution of 80%. FIBTEM (extrinsically activated assay with platelet inhibitor, primarily measuring contribution of fibrinogen to coagulation) amplitude at 5 minutes (A5) began to diminish at 35% hemodilution, with the median A5 in the coagulopathic range (<12 mm) at 55% hemodilution. The area under the curve (AUC), a marker of clot strength, for EXTEM and FIBTEM consistently declined as hemodilution increased. Greater decreases in FIBTEM AUC were seen compared to EXTEM AUC, with the ratio of FIBTEM:EXTEM AUC at each dilution demonstrating a statistically significant difference from baseline. DISCUSSION/SIGNIFICANCE OF IMPACT: All thromboelastometry values demonstrated a hypocoagulable trend as hemodilution increased. However, the samples analyzed by the FIBTEM assay trended toward a coagulopathy at a lower degree of hemodilution compared to the EXTEM assay. As FIBTEM tests analyze the role of fibrinogen in hemostasis and EXTEM tests analyze the role of platelets, our findings suggest that platelets may be able to withstand higher degrees of hemodilution before impairing hemostasis compared to fibrinogen. These findings support the growing body of literature that in early stages of severe obstetric hemorrhage, the prioritization of fibrinogen replacement may be critical in preventing further coagulopathy. CONFLICT OF INTEREST DESCRIPTION: All authors have no conflicts of interest to report.
first_indexed 2024-04-10T04:28:32Z
format Article
id doaj.art-68ff6841c3f64a38bd1a6133214db2a3
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:28:32Z
publishDate 2020-06-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-68ff6841c3f64a38bd1a6133214db2a32023-03-10T08:51:35ZengCambridge University PressJournal of Clinical and Translational Science2059-86612020-06-01414714710.1017/cts.2020.4344402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometryChloe Getrajdman0Matthew Sison1Hung-Mo Lin2Daniel Katz3Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount SinaiOBJECTIVES/GOALS: Little is known about the effect of hemodilution with crystalloid on blood coagulation in obstetric patients. The purpose of our study was to examine the impact of hemodilution on components of blood coagulation using rotational thromboelastometry (ROTEM®) in term parturients METHODS/STUDY POPULATION: This is a prospective, observational pilot study including 35 healthy, pregnant patients at term (≥37 weeks) without history of bleeding or clotting disorder or on medication affecting coagulation. Venous blood samples were collected from all patients and divided into specimen tubes to generate varying degrees of hemodilution with Plasma-Lyte (0%, 20%, 25%, 30%, 35%, 40%, 45%, 55%, 60%, 65%, 70%, 75%, 80%). Rotational thromboelastometry was then performed on samples to assess for coagulation changes. RESULTS/ANTICIPATED RESULTS: EXTEM (extrinsically activated assay) clotting time (CT) became prolonged at 65% hemodilution and above, and the median CT was in the coagulopathic range (>80 seconds) at a dilution of 80%. FIBTEM (extrinsically activated assay with platelet inhibitor, primarily measuring contribution of fibrinogen to coagulation) amplitude at 5 minutes (A5) began to diminish at 35% hemodilution, with the median A5 in the coagulopathic range (<12 mm) at 55% hemodilution. The area under the curve (AUC), a marker of clot strength, for EXTEM and FIBTEM consistently declined as hemodilution increased. Greater decreases in FIBTEM AUC were seen compared to EXTEM AUC, with the ratio of FIBTEM:EXTEM AUC at each dilution demonstrating a statistically significant difference from baseline. DISCUSSION/SIGNIFICANCE OF IMPACT: All thromboelastometry values demonstrated a hypocoagulable trend as hemodilution increased. However, the samples analyzed by the FIBTEM assay trended toward a coagulopathy at a lower degree of hemodilution compared to the EXTEM assay. As FIBTEM tests analyze the role of fibrinogen in hemostasis and EXTEM tests analyze the role of platelets, our findings suggest that platelets may be able to withstand higher degrees of hemodilution before impairing hemostasis compared to fibrinogen. These findings support the growing body of literature that in early stages of severe obstetric hemorrhage, the prioritization of fibrinogen replacement may be critical in preventing further coagulopathy. CONFLICT OF INTEREST DESCRIPTION: All authors have no conflicts of interest to report.https://www.cambridge.org/core/product/identifier/S2059866120004343/type/journal_article
spellingShingle Chloe Getrajdman
Matthew Sison
Hung-Mo Lin
Daniel Katz
4402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry
Journal of Clinical and Translational Science
title 4402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry
title_full 4402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry
title_fullStr 4402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry
title_full_unstemmed 4402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry
title_short 4402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry
title_sort 4402 the effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry
url https://www.cambridge.org/core/product/identifier/S2059866120004343/type/journal_article
work_keys_str_mv AT chloegetrajdman 4402theeffectsofhemodilutioninvitrooncoagulationintermparturientsusingthromboelastometry
AT matthewsison 4402theeffectsofhemodilutioninvitrooncoagulationintermparturientsusingthromboelastometry
AT hungmolin 4402theeffectsofhemodilutioninvitrooncoagulationintermparturientsusingthromboelastometry
AT danielkatz 4402theeffectsofhemodilutioninvitrooncoagulationintermparturientsusingthromboelastometry